Our two divisions are closely interlinked programmatically and in our predoctoral and postdoctoral training. Together, we have 37 full-time faculty members.
We are an integral part of the clinical, educational and research missions of the UCSD Moores Cancer Center.
We are deeply committed to the missions of academic medicine, including patient care, research and education.
We provide the highest quality of patient care for a wide spectrum of illnesses related to blood diseases and cancer.
Our faculty physicians are nationally and internationally recognized in solid tumor oncology, benign hematology, and hematological malignancies including acute and chronic leukemias, myeloproliferative disorders and multiple myeloma.
Our two divisions’ research activities are diverse and have a tremendous depth in a number of important areas, including stem cell biology, tumor biology and immunology, hematopoiesis, platelet and vascular biology, and cancer clinical trials.
The Department of Medicine is well supported with extramural funding. The Divisions of Hematology-Oncology and Bone Marrow Transplantation receive research funding from federal, state, and foundation sources.
We have an outstanding fellowship program that trains physicians to become leaders in the field of hematology-oncology.
We invite you to learn more about our divisions’ activities by exploring this website and we encourage you to contact us for further information.
Dr. Scott M. Lippman, new director of the UCSD Moores Cancer Center, joined UCSD in May 2012 from The University of Texas M.D. Anderson Cancer Center, where he was chief of Thoracic/Head and Neck Medical Oncology.
At UCSD, Dr. Lippman is Senior Associate Dean and Assistant Vice Chancellor for Cancer Research and Care and holds the Chugai Pharmaceutical Chair in Cancer.
His research focuses on studies of cancer risk, the development of molecularly-targeted drugs and personalized therapy.
Grants and Awards
Ida Wong-Sefidan, MD
Appointed as a member of the ASH Trainee Council in 2012.
Ida Wong-Sefidan, MD and Asit Paul, MD, PhD
Received scholarship awards to attend the 2012 American Association of Cancer Research (AACR)/ American Society of Clinical Oncology (ASCO) “Methods in Clinical Research” Workshop in Vail, Colorado.
Asit Paul, MD, PhD
Received a scholarship award to attend the June 2012 National Cancer Institute (NCI) Workshop on Cancer Imaging in Nashville,TN.
Michael Choi, MD
Received the 2012 Tower Cancer Research Foundation Career Development Award with the project title: Inhibition of Wnt Signaling to Treat Leukemic Stem Cells: A Drug Development Proposal.
ASH Clinical Research Training Institute – Selected as a participant in 2011-2012 program. Project title: A Pilot Clinical Trial of Ethacrynic Acid for the Treatment of Chronic Lymphocytic Leukemia.
Finalist, ASH Research Training Award for Fellows, 2012.
Meet Our Fellows